Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors

NCT06082960 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: GS-9911
DRUG: Zimberelimab

Sponsor

Gilead Sciences